Axecap Investments LLC Purchases Shares of 12,686 The Procter & Gamble Company (NYSE:PG)

Axecap Investments LLC purchased a new stake in shares of The Procter & Gamble Company (NYSE:PG) in the 3rd quarter, HoldingsChannel reports. The firm purchased 12,686 shares of the company’s stock, valued at approximately $2,197,000. Procter & Gamble makes up 1.7% of Axecap Investments LLC’s portfolio, making the stock its 27th largest holding.

Several other institutional investors have also added to or reduced their stakes in PG. Wulff Hansen & CO. boosted its position in Procter & Gamble by 16,292.0% during the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after buying an additional 3,653,477 shares during the period. TD Asset Management Inc boosted its position in Procter & Gamble by 114.9% during the first quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after buying an additional 1,907,716 shares during the period. AMF Tjanstepension AB boosted its position in Procter & Gamble by 416.1% during the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after buying an additional 1,466,115 shares during the period. Swedbank AB bought a new position in shares of Procter & Gamble during the first quarter valued at about $233,788,000. Finally, Ilex Capital Partners UK LLP bought a new position in shares of Procter & Gamble during the first quarter valued at about $228,212,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Trading Down 0.1 %

Shares of PG stock opened at $169.58 on Thursday. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The firm’s 50 day moving average is $171.88 and its 200 day moving average is $167.45. The stock has a market capitalization of $400.23 billion, a P/E ratio of 27.71, a P/E/G ratio of 3.72 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter last year, the company posted $1.83 earnings per share. The firm’s quarterly revenue was down .6% on a year-over-year basis. Research analysts expect that The Procter & Gamble Company will post 6.98 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 65.69%.

Wall Street Analysts Forecast Growth

PG has been the subject of several recent analyst reports. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a research note on Thursday, August 29th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Jefferies Financial Group downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and lowered their price objective for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. Finally, DA Davidson upped their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

Insider Transactions at Procter & Gamble

In other news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Susan Street Whaley sold 450 shares of the firm’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the sale, the insider now owns 13,072 shares in the company, valued at $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 385,186 shares of company stock worth $65,479,358 in the last 90 days. 0.17% of the stock is currently owned by insiders.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.